SELLAS Life Sciences Announces Preliminary Positive WT1 Cancer…
Initial results from the study, which commenced in and enrolled a total of 15 patients, have demonstrated positive immune response data and safety findings as well as early efficacy data. Three patients with high-risk cytogenetics achieved an immune re…